Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Conditions
- Prostate Cancer
- Prostate Cancer (Adenocarcinoma)
- Prostate Cancer Metastatic Disease
- Prostate Cancer Recurrent
- Prostate Carcinoma
- Prostate Neoplasm
- Prostate Adenocarcinoma
- Prostate Cancer With Bone Metastasis
- Vasomotor Disturbance
- Vasomotor Symptoms
- Vasomotor Symptoms (VMS)
- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
- Vasomotor Symptoms; Hot Flashes
- Androgen Deprivation Therapy
- Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
- Androgen-deprivation Therapy
- Hot Flashes
- Hot Flushes
- Hot Flushes and/or Sweats
Interventions
- DRUG: fezolinetant - reference formulation
- DRUG: Placebo
Sponsor
Shehzad Basaria, M.D.
Collaborators